Helmet Non-Invasive Ventilation for COVID-19 Patients (Helmet-COVID): study protocol for a multicentre randomised controlled trial

INTRODUCTION: Non-invasive ventilation (NIV) delivered by helmet has been used for respiratory support of patients with acute hypoxaemic respiratory failure due to COVID-19 pneumonia. The aim of this study was to compare helmet NIV with usual care versus usual care alone to reduce mortality. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Arabi, Yaseen M, Tlayjeh, Haytham, Aldekhyl, Sara, Al-Dorzi, Hasan M, Abdukahil, Sheryl Ann, Al Harbi, Mohammad Khulaif, Al Haji, Husain, Al Mutairi, Mohammed, Al Zumai, Omar, Al Qasim, Eman, Al Wehaibi, Wedyan, Al Qahtani, Saad, Al-Hameed, Fahad, Chalabi, Jamal, Alshahrani, Mohammed, Albrahim, Talal, Alharthy, Abdulrahman, Mady, Ahmed, Bin Eshaq, Abdulhadi, Al bshabshe, Ali A, Al Aseri, Zohair, Al Duhailib, Zainab, Kharaba, Ayman, Alqahtani, Rakan, Al Ghamdi, Adnan, Altalag, Ali, Alghamdi, Khalid, Almaani, Mohammed, Algethamy, Haifa, Al Aqeily, Ahmad, Al Baseet, Faisal, Al Samannoudi, Hashem, Al Obaidi, Mohammed, Ismaiel, Yassin T, Al-Fares, Abdulrahman A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392742/
https://www.ncbi.nlm.nih.gov/pubmed/34446500
http://dx.doi.org/10.1136/bmjopen-2021-052169
Descripción
Sumario:INTRODUCTION: Non-invasive ventilation (NIV) delivered by helmet has been used for respiratory support of patients with acute hypoxaemic respiratory failure due to COVID-19 pneumonia. The aim of this study was to compare helmet NIV with usual care versus usual care alone to reduce mortality. METHODS AND ANALYSIS: This is a multicentre, pragmatic, parallel randomised controlled trial that compares helmet NIV with usual care to usual care alone in a 1:1 ratio. A total of 320 patients will be enrolled in this study. The primary outcome is 28-day all-cause mortality. The primary outcome will be compared between the two study groups in the intention-to-treat and per-protocol cohorts. An interim analysis will be conducted for both safety and effectiveness. ETHICS AND DISSEMINATION: Approvals are obtained from the institutional review boards of each participating institution. Our findings will be published in peer-reviewed journals and presented at relevant conferences and meetings. TRIAL REGISTRATION NUMBER: NCT04477668.

Ejemplares similares